REFERENCES
1. Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management.
Future Oncol. 2010;6:229–237.
2. Vaidakis D, Karoubalis J, Pappa T, et al Pancreatic insulinoma: current issues and trends.
Hepatobiliary Pancreat Dis Int. 2010;9:234–241.
3. Halfdanarson TR, Rabe KG, et al Pancreatic neuroendocrine tumors (PNETs): incidence,
prognosis and recent trend toward improved survival. Ann Oncol. 2008;19:1727–1733.
4. Kimura W, Inoue T, Futakawa N, et al Spleen-preserving distal pancreatectomy with
conservation of the splenic artery and vein. Surgery. 1996;120:885–890.
5. Service FJ, McMahon MM, O'Brien PC, et al Functioning insulinoma incidence, recurrence, and
long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711–719.
6. Liu H, Peng C, Zhang S, et al Strategy for the surgical management of insulinomas: analysis of
52 cases. Dig Surg. 2007;24:463–470.
7. van Heerden JA, Edis AJ, Service FJ. The surgical aspects of insulinomas. Ann Surg.
1979;189:677–682.
8. Komminoth P, Heitz PU, Roth J. Human insulinomas: clinical, cellular, and molecular aspects.
Endocr Pathol. 1999;10:269–281.
9. Broughan TA, Leslie JD, Soto JM, et al Pancreatic islet cell tumors. Surgery. 1986;99:671–678.
10. Edis AJ, McIlrath DC, van Heerden JA, et al Insulinoma—current diagnosis andsurgical
management. Curr Probl Surg. 1976;13:1–45.
11. Rostambeigi N, Thompson GB. What should be done in an operating room when an insulinoma
cannot be found? Clin Endocrinol (Oxf). 2009;70:512–515.
12. Gramatica L Jr, Herrera MF, Mercado-Luna A, et al Video laparoscopic resection of
insulinomas: experience in two institutions. World J Surg. 2002;26:1297–1300.
13. Lei WY, Wang TE, Chen TL, et al Insulinoma causing hypoglycemia in a patient with type 2
diabetes. J Formos Med Assoc. 2007;106:392–396.
14. Ambacher T, Kasperk R, Schumpelick V. Rational preoperative diagnosis of insulinoma.
Chirurg. 1999;70:298–301.
15. Arafah M, Kfoury H, Naseem S. Hypoglycemia, a rare presentation of a solid pseudo papillary
neoplasm of the pancreas: a case report. Turk J Gastroenterol. 2011;22:544–547.
16. Altuntas Y, Bilir M, Ucak S, et al Reactive hypoglycemia in lean young women with PCOS and
correlations with insulin sensitivity and with beta cell function. Eur J Obstet Gynecol Reprod Biol.
2005;119:198–205.
17. Tozawa K, Tamai H, Inoue K, et al Case report; malignant peritoneal mesothelioma with
hypoglycemia suggestive of paraneoplastic syndrome. Nihon Naika Gakkai Zasshi. 2011;100:2259–
2262.
18. Cruz ML, Weigensberg MJ, Bergman RN, et al Frequency of hypoglycaemia during the
intravenous glucose tolerance test in overweight children. Int J Pediatr Obes. 2007;2:122–125.
19. Marek B, Kajdaniuk D, Kos-Kudla B, et al Insulinoma-diagnosis and treatment. Endokrynol
Pol. 2007;58:58–62.
20. Grant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin Gastroenterol.
1996;10:645–671.
21. Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332:1144–1152.
22. McPhee SJ, Nguyen T, Euler GL, et al Successful promotion of hepatitis B vaccinations among
Vietnamese-American children ages 3 to 18: results of a controlled trial. Pediatrics.
2003;111:1278–1288.
23. Vig S, Lewis M, Foster KJ, et al Lessons to be learned: a case study approach insulinoma
presenting as a change in personality. J R Soc Promot Health. 2001;121:56–61.
24. Coelho C, Druce MR, Grossman AB. Diagnosis of insulinoma in a patient with hypoglycemia
without obvious hyperinsulinemia. Nat Rev Endocrinol. 2009;5:628–631.
25. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93:264–
275.
26. Placzkowski KA, Vella A, Thompson GB, et al Secular trends in the presentation and
management of functioning insulinoma at the Mayo Clinic, 1987-2007. J ClinEndocrinol Metab.
2009;94:1069–1073.
27. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol. 2005;19:783–798.
28. Glickman MH, Hart MJ, White TT. Insulinoma in Seattle: 39 cases in 30 years. Am J Surg.
1980;140:119–125.
29. Hackert T, Hinz U, Fritz S, et al Enucleation in pancreatic surgery: indications, technique, and
outcome compared to standard pancreatic resections. Langenbecks Arch Surg. 2011;396:1197–
1203.
30. Howland G, Compbell WR, Maltby EJ, et al Dysinsulinism: convulsions and, due to islet cell
tumor of the pancreas, with operation and cure. JAMA. 1929;93:674.
31. Guettier JM, Kam A, Chang R, et al Localization of insulinomas to regions of the pancreas by
intra arterial calcium stimulation: the NIH experience. J Clin Endocrinol Metab. 2009;94:1074–
1080.
32. Galiber AK, Reading CC, Charboneau JW, et al Localization of pancreatic insulinoma:
comparison of pre- and intraoperative US with CT and angiography. Radiology. 1988;166:405–408.
33. Vinik AI, Delbridge L, Moattari R, et al Trans hepatic portal vein catheterization for
localization of insulinomas: a ten-year experience. Surgery. 1991;109: 1–11.
34. Gower WR Jr, Fabri PJ. Endocrine neoplasms (non-gastrin) of the pancreas. Semin Surg Oncol.
1990;6:98–109.
35. Angelini L, Bezzi M, Tucci G, et al The ultrasonic detection of insulinomas during surgical
exploration of the pancreas. World J Surg. 1987;11:642–647.
36. Moher D, Cook DJ, Eastwood S, et al Improving the quality of reports of meta-analyses of
randomized controlled trials: the QUOROM statement. QUOROM Group. Br J Surg.
2000;87:1448–1454.
37. Boukhman MP, Karam JH, Shaver J, et al Insulinoma—experience from 1950 to 1995. West J
Med. 1998;169: 98–104.
38. Larsson C, Skogseid B, Oberg K, et al Multiple endocrine neoplasia type 1 gene maps to
chromosome 11 and is lost in insulinoma. Nature. 1988;332:85–87.
39. Wermer P. Endocrine adenomatosis and peptic ulcer in Large Kindred. Inherited multiple
tumors and mosaic pleiotropism in man. Am J Med. 1963;35:205–212.
40. Guettier JM, Gorden P. Insulin secretion and insulin-producing tumors. Expert Rev Endocrinol
Metab. 2010;5:217–227.
41. Hirshberg B, Livi A, Bartlett DL, et al Forty-eight-hour fast: the diagnostic test for insulinoma.
J Clin Endocrinol Metab. 2000;85:3222–3226.
42. Finlayson E, Clark OH. Surgical treatment of insulinomas. Surg Clin North Am. 2004;84:775–
785.
43. Doherty GM, Doppman JL, Shawker TH, et al Results of a prospective strategy to diagnose,
localize, and resect insulinomas. Surgery. 1991;110:989–996.
44. Hirshberg B, Libutti SK, Alexander HR, et al Blind distal pancreatectomy for occult
insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194:761–764.
45. Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North
Am. 1999;28:533–554.
46. Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am. 2009;89:1105–1121.
47. Perry RR, Vinik AI. Clinical review 72: diagnosis and management of functioning islet cell
tumors. J Clin Endocrinol Metab. 1995;80:2273–2278.
48. Schumacher B, Lubke HJ, Frieling T, et al Prospective study on the detection of insulinomas by
endoscopic ultrasonography. Endoscopy. 1996;28:273–276.
49. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and
outcomes. N Engl J Med. 1986;315:1245–1250.
50. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann
Neurol. 1985;17:421–430.
51. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North
Am. 1989;18:163–183.
52. Kwong PY, Teale JD. Screening for sulphonylureas in the investigation of hypoglycaemia. J R
Soc Med. 2002; 95:381.
53. Service FJ. Recurrent hyperinsulinemic hypoglycemia caused by an insulin secreting
insulinoma. Nat Clin Pract Endocrinol Metab. 2006;2:467–470.
54. Luo Y, Liu R, Hu MG, et al Laparoscopic surgery for pancreatic insulinomas: a singleinstitution experience of 29 cases. J GastrointestSurg. 2009;13:945–950.
55. Li W, An L, Liu R, et al Laparoscopic ultrasound enhances diagnosis and localization of
insulinoma in pancreatic head and neck for laparoscopic surgery with satisfactory post surgical
outcomes. Ultrasound Med Biol. 2011;37:1017–1023.
56. An LC, Li WX, Hu MG, et al Localization diagnosis of laparoscopic ultrasonography in
laparoscopic surgery of insulinoma. Zhonghua Yi Xue Za Zhi. 2010;90:1770–1772.
57. Kuzin NM, Egorov AV, Kondrashin SA. Preoperative and intraoperative topographic diagnosis
of insulinomas. World J Surg. 1998;22:593–597.
58. Lo CY, Tam PK. Laparoscopic pancreatic resection of an insulinoma in a child. Asian J Surg.
2003;26:43–45.
59. Kurosaki Y, Kuramoto K, Itai Y. Hyper attenuating insulinoma at unenhanced CT. Abdom
Imaging. 1996;21:334–336.
60. Balthazar EJ, Chako AC. Computed tomography of pancreatic masses. Am J Gastroenterol.
1990;85:343–349.
61. Doppman JL, Shawker TH, Miller DL. Localization of islet cell tumors. Gastroenterol Clin
North Am. 1989;18:793–804.
62. Zhao YP, Zhan HX, Zhang TP, et al Surgical management of patients with insulinomas: result
of 292 cases in a single institution. J Surg Oncol. 2011;103: 169–174.
63. Jyotsna VP, Rangel N, Pal S, et al Insulinoma: diagnosis and surgical treatment. Retrospective
analysis of 31 cases. Indian J Gastroenterol. 2006;25:244–247.
64. Gouya H, Vignaux O, Augui J, et al CT, endoscopic sonography, and a combined protocol for
preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol. 2003;181:987–992.
65. Ichikawa T, Peterson MS, Federle MP, et al Islet cell tumor of the pancreas: biphasic CT versus
MR imaging in tumor detection. Radiology. 2000;216:163–171.
66. Menegaux F, Schmitt G, Mercadier M. Pancreatic insulinomas. Am J Surg.1993;165:243–248.
67. Matsuki M, Inada Y, Nakai G, et al Diffusion-weighed MR imaging of pancreatic carcinoma.
Abdom Imaging. 2007;32:481–483.
68. Geoghegan JG, Jackson JE, Lewis MP, et al Localization and surgical management of
insulinoma. Br J Surg. 1994;81:1025–1028.
69. Fulton RE, Sheedy PF, Mc ID, et al Preoperative angiographic localization of insulin-producing
tumors of the pancreas. Am J Roentgenol Radium Ther Nucl Med. 1975;123:367–377.
70. Stefanini P, Carboni M, Patrassi N. Beta-islet cell tumors of the pancreas: results of a study on
1,067 cases. Surgery. 1974;75:597–609.
71. Doppman JL, Miller DL, Chang R, et al Insulinomas: localization with selective intra arterial
injection of calcium. Radiology. 1991;178:237–241.
72. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced
neuroendocrine tumors. Endocr Rev. 2004;25:458–511.
73. Langer P, Bartsch DK, Fendrich V, et al Minimal invasive operative treatment of organic
hyperinsulinism. Dtsch Med Wochenschr. 2005;130:514–518.
74. Sotoudehmanesh R, Hedayat A, Shirazian N, et al Endoscopic ultrasonography (EUS) in the
localization of insulinoma. Endocrine. 2007;31:238–241.
75. Grover AC, Skarulis M, Alexander HR, et al A prospective evaluation of laparoscopic
exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas.
Surgery. 2005;138:1003–1008.
76. Goh BK, Ooi LL, Cheow PC, et al Accurate preoperative localization of insulinomas avoids the
need for blind resection and reoperation: analysis of a single institution experience with 17
surgically treated tumors over 19 years. J Gastrointest Surg. 2009;13:1071–1077.
77. Fernandez-Cruz L, Blanco L, Cosa R, et al Is laparoscopic resection adequate in patients with
neuroendocrine pancreatic tumors? World J Surg. 2008;32:904–917.
78. Lo CY, Chan FL, Tam SC, et al Value of intra-arterial calcium stimulated venous sampling for
regionalization of pancreatic insulinomas. Surgery. 2000;128:903–909.
79. Boukhman MP, Karam JM, Shaver J, et al Localization of insulinomas. Arch
Surg.1999;134:818–822.
80. Gianello P, Gigot JF, Berthet F, et al Pre- and intraoperative localization of insulinomas: report
of 22 observations. World J Surg. 1988;12:389–397.
81. Le Quesne LP, Nabarro JD, Kurtz A, et al The management of insulin tumours of the pancreas.
Br J Surg. 1979;66(6):373–378.
82. Doppman JL, Chang R, Fraker DL, et al Localization of insulinomas to regions of the pancreas
by intra-arterial stimulation with calcium. Ann Intern Med. 1995;123:269–273.
83. Roher HD, Simon D, Starke A, et al Special diagnostic and therapeutic aspects of insulinoma.
Chirurg. 1997;68:116–121.
84. Ravi K, Britton BJ. Surgical approach to insulinomas: are pre-operative localization tests
necessary? Ann R Coll Surg Engl. 2007;89:212–217.
85. Noldge G, Weber MA, Ritzel RA. Invasive diagnostic procedures for insulinomas of the
pancreas. Radiologe. 2009;49:224–232.
86. Brown CK, Bartlett DL, Doppman JL, et al Intraarterial calcium stimulation and intraoperative
ultrasonography in the localization and resection of insulinomas. Surgery. 1997;122:1189–1193.
87. Mirallie E, Pattou F, Malvaux P, et al Value of endoscopic ultrasonography and somatostatin
receptor scintigraphy in the preoperative localization of insulinomas and gastrinomas. Experience of
54 cases. Gastroenterol Clin Biol. 2002;26:360–366.
88. Zografos GN, Vasiliadis G, Karoubalis J, et al Laparoscopic resection of insulinoma after
endoscopic ultrasonography tattooing. Am Surg. 2010;76: 446–448.
89. Gress FG, Barawi M, Kim D, et al Preoperative localization of a neuroendocrine tumor of the
pancreas with EUS-guided fine needle tattooing. Gastrointest Endosc. 2002;55:594–597.
90. Park BJ, Alexander HR, Libutti SK, et al Operative management of islet-cell tumors arising in
the head of the pancreas. Surgery. 1998;124:1056–1061.
91. Lo CY, Lam KY, Kung AW. Pancreatic insulinomas. A 15-year experience. Arch Surg.
1997;132:926–930.
92. Amikura K, Nakamura R, Arai K, et al Role of intraoperative insulin monitoring in surgical
management of insulinoma. J Laparoendosc Adv Surg Tech A. 2001;11:193–199.
93. Gunther RW, Klose KJ, Ruckert K, et al Localization of small islet-cell tumors. Preoperative
and intraoperative ultrasound, computed tomography, arteriography, digital subtraction
angiography, and pancreatic venous sampling. Gastrointest Radiol. 1985;10:145–152.
94. Gorman B, Charboneau JW, James EM, et al Benign pancreatic insulinoma: preoperative and
intraoperative sonographic localization. AJR Am J Roentgenol. 1986;147:929–934.
95. Daneshvar K, Grenacher L, Mehrabi A, et al Preoperative tumor studies using MRI or CT in
patients with clinically suspected insulinoma. Pancreatology. 2011;11:487–494.
96. Norton JA, Shawker TH, Doppman JL, et al Localization and surgical treatment of occult
insulinomas. Ann Surg. 1990;212:615–620.
97. van Heerden JA, Grant CS, Czako PF, et al Occult functioning insulinomas: which localizing
studies are indicated? Surgery. 1992;112:1010–1014.
98. Pasieka JL, McLeod MK, Thompson NW, et al Surgical approach to insulinomas. Assessing the
need for preoperative localization. Arch Surg. 1992;127:442–447.
99. Paivansalo M, Makarainen H, Siniluoto T, et al Ultrasound compared with computed
tomography and pancreatic arteriography in the detection of endocrine tumours of the pancreas. Eur
J Radiol. 1989;9:173–178.
100. Lo CY, Lam KY, Fan ST. Surgical strategy for insulinomas in multiple endocrine neoplasia
type I. Am J Surg. 1998;175:305–307.
101. Stehouwer CD, Lems WF, Fischer HR, et al Malignant insulinoma: is combined treatment
with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective
than single therapy with either drug? Neth J Med. 1989;35:86–94.
102. Tutt GO Jr, Edis AJ, Service FJ, et al Plasma glucose monitoring during operation for
insulinoma: a critical reappraisal. Surgery. 1980;88:351–356.
103. Chung JC, Choi SH, Jo SH, et al Localization and surgical treatment of the pancreatic
insulinomas. ANZ J Surg. 2006;76:1051–1055.
104. Ritzel RA, Isermann B, Schilling T, et al Diagnosis and localization of insulinoma after
negative laparotomy by hyperinsulinemic, hypoglycemic clamp and intra-arterial calcium
stimulation. Rev Diabet Stud. 2004;1:42–46.
105. Kisker O, Bastian D, Bartsch D, et al Localization, malignant potential, and surgical
management of gastrinomas. World J Surg. 1998;22:651–657.
106. Kaplan EL, Lee CH. Recent advances in the diagnosis and treatment of insulinomas. Surg Clin
North Am. 1979;59:119–129.
107. May GR, James EM, Johnson CM. The radiologist's role in acute endocrine problems. World J
Surg. 1982;6:725–734.
108. Aldrete JS, Han SY, Henao F. Arteriography with simultaneous gastric distention to detect
insulin-secreting tumors of the pancreas. South Med J. 1983;76:1524–1529.
109. Fendrich V, Bartsch DK, Langer P, et al Diagnosis and surgical treatment of insulinoma–
experiences in 40 cases. Dtsch Med Wochenschr. 2004;129:941–946.
110. Iihara M, Kanbe M, Okamoto T, et al Laparoscopic ultrasonography for resection of
insulinomas. Surgery. 2001;130:1086–1091.
111. Stamatakos M, Safioleas C, Tsaknaki S, et al Insulinoma: a rare neuroendocrine pancreatic
tumor. Chirurgia (Bucur). 2009;104:669–673.
112. Sperti C, Pasquali C, Ferronato A, et al Median pancreatectomy for tumors of the neck and
body of the pancreas. J Am Coll Surg. 2000;190:711–716.
113. Proye C. Surgery of insulinoma. Acta Chir Belg. 1991;91:82–87.
114. Buchler MW, Wagner M, Schmied BM, et al Changes in morbidity after pancreatic resection:
toward the end of completion pancreatectomy. Arch Surg. 2003;138:1310–1314.
115. Hirono S, Tani M, Kawai M, et al Treatment strategy for intraductal papillary mucinous
neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009;144:345–349.
116. Machado MC, da Cunha JE, Jukemura J, et al Insulinoma: diagnostic strategies and surgical
treatment. A 22-year experience. Hepatogastroenterology. 2001;48:854–858.
117. Lopez CL, Waldmann J, Fendrich V, et al Long term results of surgery for pancreatic
neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg. 2011;396:1187–1196.
118. Giudici F, Nesi G, Brandi ML, et al Surgical management of insulinomas in multiple
endocrine neoplasia type 1. Pancreas. 2012;41:547–553.
119. Fischer L, Mehrabi A, Buchler MW. Neuroendocrine tumors of the duodenum and pancreas.
Surgical strategy. Chirurg. 2011;82:583–590.
120. O'Riordain DS, O'Brien T, van Heerden JA, et al Surgical management of insulinoma
associated with multiple endocrine neoplasia type I. World J Surg. 1994;18:488–493.
121. Demeure MJ, Klonoff DC, Karam JH, et al Insulinomas associated with multiple endocrine
neoplasia type I: the need for a different surgical approach. Surgery. 1991;110:998–1004.
122. Goretzki PE, Starke A, Akca A, et al Surgery for neuroendocrine tumors of the
gastroenteropancreatic system (GEP-NET). Internist (Berl). 2012;53:152–160.
123. Zerbi A, Capitanio V, Boninsegna L, et al Surgical treatment of pancreatic endocrine tumours
in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg.
2011;396:313–321.
124. Rindi G, Capella C, Solcia E. Introduction to a revised clinicopathological classification of
neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med. 2000;44:13–21.
125. Hochwald SN, Zee S, Conlon KC, et al Prognostic factors in pancreatic endocrine neoplasms:
an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol.
2002;20:2633–2642.
126. Danforth DN Jr, Gorden P, Brennan MF. Metastatic insulin-secreting carcinoma of the
pancreas: clinical course and the role of surgery. Surgery. 1984;96:1027–1037.
127. Ayav A, Bresler L, Brunaud L, et al Laparoscopic approach for solitary insulinoma: a
multicentre study. Langenbecks Arch Surg. 2005;390:134–140.
128. Isla A, Arbuckle JD, Kekis PB, et al Laparoscopic management of insulinomas. Br J Surg.
2009;96:185–190.
129. Berends FJ, Cuesta MA, Kazemier G, et al Laparoscopic detection and resection of
insulinomas. Surgery. 2000;128:386–391.
130. Isla A, Arbuckle JD, Kekis PB, et al Laparoscopic management of insulinomas. Br J Surg.
2009;96:185–190.
131. Norton JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann
Oncol. 1999;10(suppl 4):182–184.
132. Thompson GB, Service FJ, van Heerden JA, et al Reoperative insulinomas, 1927 to 1992: an
institutional experience. Surgery. 1993;114:1196–1204.
133. Proye C, Pattou F, Carnaille B, et al Intraoperative insulin measurement during surgical
management of insulinomas. World J Surg. 1998;22:1218–1224.
134. Grant AG, Grant DA. The identification of a novel NCA-related pancreatic tumour–associated
antigen, DD9-antigen: a comparison with the expression of other tumour antigens by the pancreatic
tumour cell line GER. Pancreas. 1991;6:132–141.
135. Stabile Ianora AA, Muscogiuri E, Scardapane A, et al Multislice CT in the study of
insulinomas: preliminary experience. Radiol Med. 2004;107:325–331.
136. Galbut DL, Markowitz AM. Insulinoma: diagnosis, surgical management and long-term
follow-up. Review of 41 cases. Am J Surg. 1980; 139:682–690.
137. Bassi C, Dervenis C, Butturini G, et al Postoperative pancreatic fistula: an international study
group (ISGPF) definition. Surgery. 2005;138:8–13.
138. Molinari E, Bassi C, Salvia R, et al Amylase value in drains after pancreatic resection as
predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients.
Ann Surg. 2007;246:281–287.
139. Pannegeon V, Pessaux P, Sauvanet A, et al Pancreatic fistula after distal pancreatectomy:
predictive risk factors and value of conservative treatment. Arch Surg. 2006;141:1071–1076.
140. Yoshioka R, Saiura A, Koga R, et al Risk factors for clinical pancreatic fistula after distal
pancreatectomy: analysis of consecutive 100 patients. World J Surg. 2010;34:121–125.
141. Kooby DA, Gillespie T, Bentrem D, et al Left-sided pancreatectomy: a multicenter comparison
of laparoscopic and open approaches. Ann Surg. 2008;248:438–446.
142. Mabrut JY, Fernandez-Cruz L, Azagra JS, et al Laparoscopic pancreatic resection: results of a
multicenter European study of 127 patients. Surgery. 2005;137:597–605.
143. Nikfarjam M, Warshaw AL, Axelrod L, et al Improved contemporary surgical management of
insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247:165–
172.
144. Falconi M, Zerbi A, Crippa S, et al Parenchyma-preserving resections for small
nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol. 2010;17:1621–1627.
145. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin
analogues: a review. Digestion. 2000;62(suppl. 1):84–91.
146. Hirshberg B, Cochran C, Skarulis MC, et al Malignant insulinoma: spectrum of unusual
clinical features. Cancer. 2005;104:264–272.
147. Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey.
Postgrad Med J. 1997;73:640–641.
148. Goode PN, Farndon JR, Anderson J, et al Diazoxide in the management of patients with
insulinoma. World J Surg. 1986;10:586–592.
149. Cohen MS, Bower RH, Fidler SM, et al Inhibition of insulin release by diphenylhydantoin and
diazoxide in a patient with benign insulinoma. Lancet. 1973;1:40–41.
150. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.
Gastroenterology. 2008;135:1469–1492.
151. Vezzosi D, Bennet A, Rochaix P, et al Octreotide in insulinoma patients: efficacy on
hypoglycemia, relationships with octreoscan scintigraphy and immunostaining with anti-sst 2A and
anti-sst 5 antibodies. Eur J Endocrinol. 2005;152:757–767.
152. Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors
(pNETs): recent insights and advances. J Gastroenterol. 2012;47:941–960.
153. Kulke MH, Bergsland EK, Yao JC. Glycemic control in patients with insulinoma treated with
everolimus. N Engl J Med. 2009;360:195–197.
154. Fiebrich HB, Siemerink EJ, Brouwers AH, et al Everolimus induces rapid plasma glucose
normalization in insulinoma patients by effects on tumor as well as normal tissues. Oncologist.
2011;16:783–787.
155. Levy MJ, Thompson GB, Topazian MD, et al US-guided ethanol ablation of insulinomas: a
new treatment option. Gastrointest Endosc. 2012;75:200–206.
156. Strosberg J, Hoffe S, Gardner N, et al Effective treatment of locally advanced endocrine
tumors of the pancreas with chemoradiotherapy. Neuroendocrinology. 2007;85:216–220.
157. Huscher CG, Mingoli A, Sgarzini G, et al Image-guided robotic radiosurgery (CyberKnife) for
pancreatic insulinoma: is laparoscopy becoming old? [published online ahead of print December 30,
20122] Surg Innov. Surg Innov. 2012;19:NP14–NP17.
158. Starke A, Saddig C, Mansfeld L, et al Malignant metastatic insulinoma postoperative treatment
and follow-up. World J Surg. 2005;29:789–793.
159. Norton JA, Kivlen M, Li M, et al Morbidity and mortality of aggressive resection in patients
with advanced neuroendocrine tumors. Arch Surg. 2003;138:859–866.
160. Gedaly R, Daily MF, Davenport D, et al Liver transplantation for the treatment of liver
metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg.
2011;146:953–958.
161. Fonkalsrud EW, Dilley RB, Longmire WP Jr. Insulin Secreting Tumors of the Pancreas. Ann
Surg. 1964;159:730–741.
162. Sailer R, Katoh E, Druneklee D, et al Experience in the treatment of islet adenomas (author's
translation). MMW Munch Med Wochenschr. 1976;118:429–434.
163. Dunnick NR, Long JA Jr, Krudy A, et al Localizing insulinomas with combined radiographic
methods. AJR Am J Roentgenol. 1980;135:747–752.
164. Pedrazzoli S, Feltrin G, Dodi G, et al Usefulness of transhepatic portal catheterization in the
treatment of insulinomas. Br J Surg. 1980;67:557–561.
165. Wolff VH, Lippert H, Mau H. Diagnosis and surgical therapy of organic hyperinsulinism. Zbl
Chirurgie. 1985;110:811–820.
166. Yamauchi H, Miyagawa K, Maeda M, et al Surgical management of insulinoma: diagnosis of
tumor location and high incidence of malignancy. Jpn J Surg. 1986;16:8–15.
167. Katz LB, Aufses AH Jr, Rayfield E, et al Preoperative localization and intraoperative glucose
monitoring in the management of patients with pancreatic insulinoma. Surg Gynecol Obstet.
1986;163:509–512.
168. Klotter HJ, Ruckert K, Kummerle F, et al The use of intraoperative sonography in endocrine
tumors of the pancreas. World J Surg. 1987;11:635–641.
169. Zeng XJ, Zhong SX, Zhu Y, et al Insulinoma: 31 years of tumor localization and excision. J
Surg Oncol. 1988;39:274–278.
170. Grant CS, Charboneau JW, Reading CC, et al Insulinoma: the value of intraoperative
ultrasonography. Wien Klin Wochenschr. 1988;100:376–380.
171. Bottger TC, Weber W, Beyer J, et al Value of tumor localization inpatients with insulinoma.
World J Surg. 1990;14:107–112.
172. Geissler N, Mendel V, Heymann H. Insulinoma. Results of surgical treatment. Zentralbl Chir.
1990;115:51–56.
173. Martensson H, Bottcher G, Sundler F, et al Localization and peptide content of endocrine
pancreatic tumors. Ann Surg. 1990;212:607–614.
174. Rothmund M, Angelini L, Brunt LM, et al Surgery for benign insulinoma: an international
review. World J Surg. 1990;14:393–398.
175. Palazzo L, Roseau G, Salmeron M. Endoscopic ultrasonography in the preoperative
localization of pancreatic endocrine tumors. Endoscopy. 1992;24(suppl 1):350–353.
176. Nakamura R, Takeda K, Kimura M, et al Role of intraoperative ultrasonography in the surgical
management of insulinomas. J Hepatol Bil Pancreat Surg. 1994;1:535–541.
177. Thompson NW, Czako PF, Fritts LL, et al Role of endoscopic ultrasonography in the
localization of insulinomas and gastrinomas. Surgery. 1994;116:1131–1138.
178. Pedrazzoli S, Pasquali C, Alfano D'Andrea A. Surgical treatment of insulinoma. Br J Surg.
1994;81:672–676.
179. Pitre J, Soubrane O, Palazzo L, et al Endoscopic ultrasonography for the preoperative
localization of insulinomas. Pancreas. 1996;13:55–60.
180. Zimmer T, Stolzel U, Bader M, et al Endoscopic ultrasonography and somatostatin receptor
scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996;39:562–
568.
181. Correnti S, Liverani A, Antonini G, et al Intraoperative ultrasonography for pancreatic
insulinomas. Hepatogastroenterology. 1996;43:207–211.
182. Huai JC, Zhang W, Niu HO, et al Localization and surgical treatment of pancreatic
insulinomas guided by intraoperative ultrasound. Am J Surg. 1998;175:18–21.
183. Simon D, Starke A, Goretzki PE, et al Reoperative surgery for organic hyperinsulinism:
indications and operative strategy. World J Surg. 1998;22:666–671.
184. Marubayashi S, Tanaka T, Shimizu Y, et al Tumor localization studies and surgical treatment
in patients with insulinoma. Hiroshima J Med Sci. 1998;47:69–72.
185. Jordan PH Jr. A personal experience with pancreatic and duodenal neuroendocrine tumors. J
Am Coll Surg. 1999;189:470–482.
186. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am
Coll Surg. 1999;189:368–373.
187. Ardengh JC, Rosenbaum P, Ganc AJ, et al Role of EUS in the preoperative localization of
insulinomas compared with spiral CT. Gastrointest Endosc. 2000;51:552–555.
188. Chavan A, Kirchhoff TD, Brabant G, et al Role of the intra-arterial calcium stimulation test in
the preoperative localization of insulinomas. Eur Radiol. 2000;10:1582–1586.
189. Chirletti P, Caronna R, Tamburrano G, et al Topographic diagnosis and surgical treatment of
insulinoma. Chir Ital. 2000;52:11–16.
190. Anderson MA, Carpenter S, Thompson NW, et al Endoscopic ultrasound is highly accurate
and directs management in patients with neuroendocrine tumors of the pancreas. Am J
Gastroenterol. 2000;95:2271–2277.
191. Hiramoto JS, Feldstein VA, LaBerge JM, et al Intraoperative ultrasound and preoperative
localization detects all occult insulinomas. Arch Surg. 2001;36:1020–1025. discussion 1025–1026.
192. Feng LS, Ma XX, Tang Z, et al Diagnosis and treatment of insulinoma: report of 105 cases.
Hepatobiliary Pancreat Dis Int. 2002;1:137–139.
193. Chen X, Cai WY, Yang WP, et al Pancreatic insulinomas: diagnosis and surgical treatment of
74 patients. Hepatobiliary Pancreat Dis Int. 2002;1:458–461.
194. Fidler JL FJ, Reading CC, Andrews JC, et al Preoperative detection of pancreas insulinomas
on multiphasic helical CT. AJR. 2003;181:775–780.
195. Kirchhoff TD, Merkesdal S, Frericks B, et al Intraarterial calcium stimulation (ASVS) for
pancreatic insulinoma: comparison of preoperative localization procedures. Radiologe.
2003;43:301–305.
196. Kaczirek K, Ba-Ssalamah A, Schima W, et al The importance of preoperative localisation
procedures in organic hyperinsulinism–experience in 67 patients. Wien Klin Wochenschr.
2004;116:373–378.
197. Lo CY, Chan WF, Lo CM, et al Surgical treatment of pancreatic insulinomas in the era of
laparoscopy. Surg Endosc. 2004;18:297–302.
198. Toniato A, Meduri F, Foletto M, et al Laparoscopic treatment of benign insulinomas localized
in the body and tail of the pancreas: a single center experience. World J Surg. 2006;30:1916–1919.
199. Kang CM, Park SH, Kim KS, et al Surgical experiences of functioning neuroendocrine
neoplasm of the pancreas. Yonsei Med J. 2006;47:833–839.
200. Sa Cunha A, Beau C, Rault A, et al Laparoscopic versus open approach for solitary
insulinoma. Surg Endosc. 2007;21:103–108.
201. Casanova D, Polavieja MG, Naranjo A, et al Surgical treatment of persistent hyperinsulinemic
hypoglycemia (PHH) (insulinoma and nesidioblastosis). Langenbecks Arch Surg. 2007;392:663–
670.
202. Kann PH, Ivan D, Pfutzner A, et al Preoperative diagnosis of insulinoma: low body mass
index, young age, and female gender are associated with negative imaging by endoscopic
ultrasound. Eur J Endocrinol. 2007;157:209–213.
203. Liu H, Zhang SZ, Wu YL, et al Diagnosis and surgical treatment of pancreatic endocrine
tumors in 36 patients: a single-center report. Chin Med J (Engl). 2007;120:1487–1490.
204. Tseng LM, Chen JY, Won JG, et al The role of intra-arterial calcium stimulation test with
hepatic venous sampling (IACS) in the management of occult insulinomas. Ann Surg Oncol.
2007;14:2121–2127.
205. Karakoc D, Ozdemir A, Sayek I. Insulinoma: an evaluation by a single institution. Acta Chir
Belg. 2008;108:569–573.
206. Hoem D, Jensen D, Steine S, et al Clinicopathological characteristics and non-adhesive organ
culture of insulinomas. Scand J Surg. 2008;97:42–49.
207. Begu-Le Corroller A, Valero R, Moutardier V, et al Aggressive multimodal therapy of
sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients.
Diabetes Metab. 2008;34:343–348.
208. Roland CL, Lo CY, Miller BS, et al Surgical approach and perioperative complications
determine short-term outcomes in patients with insulinoma: results of a bi-institutional study. Ann
Surg Oncol. 2008;15:3532–3537.
209. Paul TV, Jacob JJ, Vasan SK, et al Management of insulinomas: analysis from a tertiary care
referral center in India. World J Surg. 2008;32:576–582.
210. Espana-Gomez MN, Velazquez-Fernandez D, Bezaury P, et al Pancreatic insulinoma: a
surgical experience. World J Surg. 2009;33:1966–1970.
211. Morganstein DL, Lewis DH, Jackson J, et al The role of arterial stimulation and simultaneous
venous sampling in addition to cross-sectional imaging for localisation of biochemically proven
insulinoma. Eur Radiol. 2009;19:2467–2473.
212. Goretzki P, Starke A, Lammers B, et al Pancreatic hyperinsulinism changes of the clinical
picture and importance of differences in sporadic disease course (experience with 144 patients
operated in the period 1986-2009). Zentralbl Chir. 2010;135:218–225.
213. Druce MR, Muthuppalaniappan VM, O'Leary B, et al Diagnosis and localization of
insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium
stimulation catheterisation. Eur J Endocrinol. 2010;162:971–978.
214. Gopal RA, Acharya SV, Menon SK, et al Clinical profile of insulinoma: analysis from a
tertiary care referral center in India. Indian J Gastroenterol. 2010;29:205–208.
215. Varma V, Tariciotti L, Coldham C, et al Preoperative localisation and surgical management of
insulinoma: single centre experience. Dig Surg. 2011;28:63–73.
216. Hu M, Zhao G, Luo Y, et al Laparoscopic versus open treatment for benign pancreatic
insulinomas: an analysis of 89 cases. Surg Endosc. 2011;25:3831–3837.
217. An L, Li W, Yao KC, et al Assessment of contrast-enhanced ultrasonography in diagnosis and
preoperative localization of insulinoma. Eur J Radiol. 2011;80:675–680.
218. Hofeldt FD, Dippe SE, Levin SR, et al Effects of diphenylhydantoin upon glucose-induced
insulin secretion in three patients with insulinoma. Diabetes. 1974;23:192–198.